Back to basics- a UK perspective on "Make lithium great again" Malhi et al

Joel Winstanley; Allan H Young; Sameer Jauhar

doi:10.1111/bdi.13002

Back to basics- a UK perspective on "Make lithium great again" Malhi et al

Joel Winstanley, Allan H Young, Sameer Jauhar

SLaM South London and Maudsley NHS Foundation Trust
Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust (SLaM) and King's College London, London, United Kingdom.

Research output: Contribution to journal › Comment/debate › peer-review

48 Downloads (Pure)

Abstract

We agree in general with Malhi et al's forthright Editorial "Make Lithium Great Again", where they reiterate that, despite its clear efficacy and effectiveness, lithium remains under-utilised in the treatment of bipolar disorder. Possible reasons they give for this include prescription of second generation antipsychotics (SGAs), which may appear easier to prescribe, are marketed better, and may appear to require less monitoring.

Original language	English
Journal	Bipolar Disorders
Early online date	26 Sept 2020
DOIs	https://doi.org/10.1111/bdi.13002
Publication status	E-pub ahead of print - 26 Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bdi.13002

Back to basics- a _WINSTANLEY_Acc26Sep2020_GREEN AAMAccepted author manuscript, 120 KB

Cite this

@article{3a10efa0ab514469a7cb33ef2c5b97f4,

title = "Back to basics- a UK perspective on {"}Make lithium great again{"} Malhi et al",

abstract = "We agree in general with Malhi et al's forthright Editorial {"}Make Lithium Great Again{"}, where they reiterate that, despite its clear efficacy and effectiveness, lithium remains under-utilised in the treatment of bipolar disorder. Possible reasons they give for this include prescription of second generation antipsychotics (SGAs), which may appear easier to prescribe, are marketed better, and may appear to require less monitoring.",

author = "Joel Winstanley and Young, {Allan H} and Sameer Jauhar",

year = "2020",

month = sep,

day = "26",

doi = "10.1111/bdi.13002",

language = "English",

journal = "Bipolar Disorders",

issn = "1398-5647",

publisher = "Blackwell Munksgaard",

}

TY - JOUR

T1 - Back to basics- a UK perspective on "Make lithium great again" Malhi et al

AU - Winstanley, Joel

AU - Young, Allan H

AU - Jauhar, Sameer

PY - 2020/9/26

Y1 - 2020/9/26

N2 - We agree in general with Malhi et al's forthright Editorial "Make Lithium Great Again", where they reiterate that, despite its clear efficacy and effectiveness, lithium remains under-utilised in the treatment of bipolar disorder. Possible reasons they give for this include prescription of second generation antipsychotics (SGAs), which may appear easier to prescribe, are marketed better, and may appear to require less monitoring.

AB - We agree in general with Malhi et al's forthright Editorial "Make Lithium Great Again", where they reiterate that, despite its clear efficacy and effectiveness, lithium remains under-utilised in the treatment of bipolar disorder. Possible reasons they give for this include prescription of second generation antipsychotics (SGAs), which may appear easier to prescribe, are marketed better, and may appear to require less monitoring.

UR - http://www.scopus.com/inward/record.url?scp=85092458246&partnerID=8YFLogxK

U2 - 10.1111/bdi.13002

DO - 10.1111/bdi.13002

M3 - Comment/debate

C2 - 32979022

SN - 1398-5647

JO - Bipolar Disorders

JF - Bipolar Disorders

ER -

Back to basics- a UK perspective on "Make lithium great again" Malhi et al

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this